// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A pilot study to consider implementing a validated tool to improve the objective assessment method of methotrexate intolerance for a paediatric rheumatology department

Catherine Tranter - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methotrexate

Protocol for the two-cohort, open-label, single-arm EMERALD study of emapalumab, an anti-interferon gamma monoclonal antibody, in patients with macrophage activation syndrome in rheumatic diseases

Paul Brogan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Macrophage activation syndrome

Interferon Gamma

Outcomes following switching from originator to biosimilar product in children and young people with JIA

Lianne Kearsley-Fleet - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Imagined Futures: How can digital storytelling empower young people with JIA to engage in ideas about health, wellbeing and transition

Anna Woolf - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Clinical outcomes and care quality standards in young adult patients with early inflammatory arthritis: Results from a national cohort

Maryam Adas - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Early inflammatory arthritis

N/A

Fibromyalgia correlates with neurodivergent traits in a self-selected community population

Laura Ryan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibromyalgia

N/A

Exploring fibromyalgia patients by gender using routinely collected primary-care data from Wales, UK: a descriptive epidemiological study

Roxanne Cooksey - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibromyalgia

N/A

The risks of adverse events with analgesics in patients with inflammatory arthritis: a systematic review of observational studies

Christopher R White - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Changes in Analgesic Prescribing in Patients with Inflammatory Arthritis in England: An Observational Study in CPRD Aurum

Ian C Scott - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Attention-based Virtual Reality - A Safe, Acceptable and Potentially Highly Effective Treatment for Fibromyalgia Syndrome: Findings from The VIPA Study

Jordan Tsigarides - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Fibromyalgia

N/A

The Impact of Intensive Management on Pain Intensity in Patients with Rheumatoid Arthritis and Psoriatic Arthritis: Secondary Analysis of Three Clinical Trials

Ian C Scott - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Rheumatoid arthritis

Methotrexate

Understanding First Contact Physiotherapists experiences of remote consultations in primary care

Nicola Walsh - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Barriers and facilitators to lifestyle change in people living with gout: a scoping review of qualitative studies

Lorraine Watson - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Gout

N/A

The impact of the COVID-19 pandemic on primary care referrals and new diagnoses of inflammatory arthritis

Ram Bajpai - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory Arthritis

N/A

The role of occupational therapy for the self-management of rheumatoid arthritis: a mixed methods systematic review

James P Gavin - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Mode of hospital rheumatology appointments in people with rheumatoid arthritis: the impact of the pandemic in England

Ruth E Costello - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Feasibility Study of Methotrexate use Improvement in Rheumatoid Arthritis using Biomarker Feedback: The MIRA Trial

James Bluett - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

Long-term efficacy of baricitinib in patients with rheumatoid arthritis with inadequate response to bDMARDs: results from RA-BEYOND up to 6.9-years of treatment

Roberto Caporali - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Baricitinib

Exploring the Treatment Burden of Disease Modifying Anti-Rheumatic Drug Monitoring in People with Rheumatoid Arthritis: A Qualitative Study with Recommendations for Practice

Sarah J Ryan - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Personalised comprehensive care packages for people with rheumatoid arthritis: a survey-based study

Mrinalini Dey - British Society for Rheumatology (BSR) , 2023

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved